DISSEMINATION ACTIVITIES

Dissemination and communication activities completed during the 1st period of the project (January 2018 – June 2019

WP2

Webinars (5)

DICE Fundamentals 

DICE Components 

DICE Model Events 

DICE Blueprint 

DICE Complete Blueprint

WP2

Poster

Jun-19

Cologne, Germany

HTAi 2019

The DICE method

WP2

Flyer

Jun-19

Cologne, Germany

HTAi 2019 

DICE Simulation: a new method that facilitates decision-analytic modeling

WP2

Conference presentation

Mar-18

Orlando, USA

ASCPT

Leveraging DICE to incorporate pharmacometrics in PE models

WP2

Conference course

May-18

Baltimore, USA

ISPOR NA

Using DICE Simulation for Health Economic Analyses

WP2

Conference workshop

Sep-18

Tokyo, Japan

ISPOR Asia 2018

Response Based Cost-Effectiveness Modeling in Immuno-Oncology

WP2

Conference presentation

Oct-18

Pennsylvania, USA 

Merck Annual Research Day

Model Transparency, Validation/Qualification, Sharing, Reproducibility

WP2

Conference course

Nov-18

Barcelona, Spain

ISPOR EU 2018

Using DICE Simulation for Health Economic Analyses

WP2

Conference course

Feb-19

Singapore

NUS

Advanced Modelling in HTA

WP2

Conference course

May-19

New Orleans, USA

ISPOR 2019

Using DICE Simulation for HE

WP2

Conference workshop

Jun-19

Cologne, Germany

HTAi 2019

DICE Simulation for HTA

WP3

Press release

Mar-18

Escuela Andaluza de Salud Pública participa en un proyecto europeo para estandarizar la evaluación de costes sanitarios

www.lavanguardia.com/local/sevilla/20180316/441569914458/escuela-andaluza-de-salud-publica-participa-en-un-proyecto-europeo-para-estandarizar-la-evaluacion-de-costes-sanitarios.html

WP3

Press release

Mar-18

La EASP participa en la puesta en marcha de una base de datos europea de costes sanitarios

www.actasanitaria.com/dimes_y_diretes/la-easp-participa-en-la-puesta-en-marcha-de-una-base-de-datos-europea-de-costes-sanitarios

WP3

Press release

Mar-18

La EASP participa en en un proyecto de investigacion y la puesta en marcha de una base de datos europea de costes sanitarios

www.easp.es/wp-content/uploads/2019/06/NoticiaPortal.pdf

WP3

Press release

Jun-19

La Escuela Andaluza de Salud Pública lidera el desarrollo de una base de datos para comparar costes en la UE

www.diariofarma.com/2018/05/18/la-escuela-andaluza-de-salud-publica-lidera-el-desarrollo-de-una-base-de-datos-para-comparar-costes-en-la-ue

WP3

Organized session

Jun-18

Las Palmas de Gran Canaria (Spain)

XXXVIII Spanish Conference of Health Economics 

Enhancing the methodology and impact of economic HTA in the EU

WP3

Oral Communication

Jun-19

Albacete  (Spain)

XXXIV Spanish Conference of Health Economics

A general framework for classifying costing methods for economic evaluation of health care

WP3

Panel Session

Jun-19

Cologne (Germany)

HTAi 2019

Regional and Country Case Studies on HTA and the Evolving Macro-System of Decision Making

WP3

Journal article (submitted)

May-19

EJHE-D-19-00186

The European Journal of Public Health

A general framework for classifying costing methods for economic evaluation of health care

WP4

Conference presentation

Jun-19

Albacete, Spain

Spanish Health Economic Conference 2019 

¿Cómo De Importantes Son Los Costes Sociales En Las Evaluaciones Económicas? El Caso De La Enfermedad De Alzheimer

WP4

Journal article (submitted)

Jun-19

EJHE-D-19-00149

The European Journal of Health Economics

How relevant are social costs in economic evaluations? The case of Alzheimer’s disease

WP7

Conference presentation

Jul-18

Maastrich, Netherlands

EUHEA 12th European Conference on Health Economics

Multi-Criteria Decision Analysis for Health Technology Assessment: From state of the art towards methodological challenges

WP7

Conference presentation

Sep-18

Aveiro, Portugal

IO2018 XIX Congress of the Portuguese Association of Operational Researc

Multi-Criteria Decision Analysis for Health Technology Assessment: Which agenda to address methodological challenges?

WP7

Conference presentations (2)

May-19

Cascais, Portugal

Cimeira de Cascais: Value Improvement in Health and Care 

1. Multi-Criteria Decision Analysis for Health Technology Assessment: Value modelling tools and challenges.

2. Novel approaches to involve health stakeholders for collaborative value modelling

WP7

Conference presentation

May-19

Madeira, Portugal

EURO International Conference on Decision Support System Technology 

Collaborative value modelling in widely participated decision Support processes

WP7

Conference presentation

Jun-19

Cologne, Germany

HTAi 2019 Annual Meetin

MCDA For HTA: Which Agenda To Address Methodological Challenges?

WP7

Panel discussion

Jun-19

Cologne, Germany

HTAi 2019

Annual Meeting HTA In Europe Post 2020

WP7

Journal article

2019

10.1007/s10198-019-01052-3

Mónica D Oliveira, Inês Mataloto, Panos Kanavos. Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art. The European Journal of Health Economics, April 2019, 1–28.

https://link.springer.com/article/10.1007%2Fs10198-019-01052-3

WP7

Conference publication

2019

Carlos A Bana e Costa, Ana CL Vieira, Mónica D Oliveira, João Bana e Costa. Collaborative value modelling in widely participated decision support processes. EMC-ICDSST 2019 Proceedings – online version, Euro mini international conference on decision support system technology, 2019, 136–140

WP8

Poster

Oct-18

Riva del Garda (ITALY

Annual meeting of the Italian Society of Hygiene (SItI)

Organizational and managerial factors affecting the implementation of technologies in hospital settings: a systematic literature review

WP8

Conference presentation

Nov-18

Ljubljana, Slovenia

11th European Public Health Conference 

Measuring and benchmarking performance in secondary care settings: the state of the art

WP8

Conference presentation

Jun-19

Cologne, Germany

HTAi 2019 Annual Meeting 

Conceptual framework for understanding hospitals’ performance variability

WP8

Conference presentation

Jun-19

Lisbon, Portugal

European Academy of management (EURAM) 2019 

Hospital contextual factors affecting the use of health technologies: a systematic review

WP9

Conference

 May 2019

 Rome, Italy

Vaccinarsì Consapevolmente (engaged in vaccination)

WP9

Social media

May-19

 Rome, Italy

WP10

Workshop

Nov-18

Barcelona, Spain

World Orphan Drug Conference 2018

Managed Access … Are they the holy grail?

WP10

Workshop

Jun-19

Köln, Germany

HTAi 2019 (full day workshop in professional society’s conference)

Appraising treatments for rare diseases

WP10

Workshop

May-19

London, UK

NICE Managed Access Agreements

WP10

Research Bulletin

April 2018 – on-going

Sent to HTA experts when needed

WP10

Conference presentation

Oct-18

Brussels, Belgium

MAP BioPharma Commercial Symposium

Overcoming HTA Challenges for Rare Disease Treatments

WP10

Conference presentation

Nov-18

Lausanne, Switzerland

eMBA Symposium, HEC 

Health technology assessment and rare diseases: Challenges and ways forward

WP10

Conference presentation

Dec-18

Berlin, Germany

NextLevel Pharma Commercial Conference 

What is special about treatments for rare diseases from an HTA perspective?

WP10

Conference panel discussion

Feb-19

Brussels, Belgium

EURORDIS Symposium

Pricing and reimbursement of treatments for rare diseases

WP10

Conference presentation

May-19

Toronto, Canada

Northwind 12th Annual Life Sciences Invitational Forum Health and Bio/Life Sciences

Appraisal of Rare Disease Treatments – What can EU Research Tell Us?

WP10

Event

May-19

Paris, France

OECD Pharmaceuticals Annual Expert Meeting

Outcome-based Managed Entry Agreements – 17 years of reflection

WP10

Joint activity with other H2020 projects

Apr-19

Amsterdam, Netherlands

EUnetHTA Forum

Active participation in discussions to cross reference to other H2020 projects and meeting to discuss overlap with HTX

Dissemination and communication activities completed during the 2nd period of the project (July 2019 – June 2021)

WP3

Oral presentation

27-Sep-19

Granada (Spain)

IMPACT-HTA: Improved Methods and Actionable Tools for Enhancing Health Technology Assessment/description and explication of European Healthcare and Social Cost Database (EU HCSCD) to the general public

WP3

Poster

2–6 November 2019

Copenhagen (Denmark)

Development of the European Healthcare Cost Database (EU HCCD) for economic evaluation of health technologies/ poster made for ISPOR Europe 2019

WP3

Lecture

19-Nov-19

Granada (Spain)

Costs. IMPACT-HTA project/ Explanation of costing methodology and European Healthcare and Social Cost Database (EU HCSCD) in Course in Methodology of economic evaluation of medicines and healthcare technologies

WP3

Oral presentation

28-Nov-19

Barcelona (Spain)

The development of the European healthcare costs database in order to strengthen the use of evaluation of healthcare technologies: IMPACT-HTA project/ oral presentation made in VI Workshop EEconAES 2019

WP3

Poster

16–19 November 2020

Virtual

Adjusting costs for inflation in economic evaluation of healthcare/ poster presented in ISPOR Europe 2020

WP3

Oral presentation

25-Nov-20

Virtual

Description of day case costs and tariffs of cataract surgery from a sample of nine European countries. Analysis of data from European Healthcare and Social Cost Database (EU HCSCD)/ oral presentation made in II Workshop GestionAES 2020

WP3

Oral presentation

27-Nov-20

Virtual

Health does not have a price, but it does have a cost: differences in unit costs across Europe/ this event was part of European Researchers‘ Night (European Corner)

WP3

Oral presentation

17-Mar-21

Virtual

Are costs derived from Diagnosis-Related Groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database/ the presentation was made at VII Workshop EEconAES. Investigation in Economic Evaluation

WP3

Oral presentation

17-Mar-21

Virtual

Adjusting costs for economic evaluation of healthcare/the presentation was made at VII Workshop EEconAES. Investigation in Economic Evaluation

WP4

International Congress Communication (Participation to a Conference)

2–6 November 2019

International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Copenhagen, Denmark.

The role played by social costs in economic evaluations of rare disease interventions. Communication accepted on the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) congress/Communication presented as 'Poster' on ISPOR Europe 2019 congress. Economic evaluations carried out from a societal perspective are still scarce in the rare diseases. Perhaps, that could be the reason why the inclusion of societal costs has changed authors’ conclusions in just 1 study of 26 economic evaluations reviewed in this case study.

WP4

International Congress Communication (Participation to a Conference)

16–19 November 2020

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Virtual

Assessing the effect of including social costs in economic evaluations: a systematic review of diabetes-related interventions / Communication presented as 'Poster' on Virtual ISPOR Europe 2020 congress. The results achieved in this case study stated that very few studies consider social costs in economic evaluations of diabetes-related interventions. However, we conclude that conclusions can be altered if they are included.

WP4

International Congress Communication (Participation to a Conference)

16–19 November 2020

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Virtual

Considering the Societal Perspective in Economic Evaluations: A Systematic Review in the Case of Depression-Related Interventions. / Communication presented as 'Poster' on Virtual ISPOR Europe 2020 congress. Our results showed that societal perspective might alter the conclusions in cost-utility analyses when depression-related interventions are economic assessed. Hence, the relevance of the perspectives of costs analysis matters on depression field.

WP4

International Congress Communication (Participation to a Conference)

16–19 November 2020

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Virtual

Social Costs in Multiple Sclerosis Economic Evaluations: Do Their Inclusion Change the Results and Conclusions? a Systematic Review / Communication presented as 'Poster' on Virtual ISPOR Europe 2020 congress. Compared with other diseases, social costs were more frequently included in economic evaluations of multiple sclerosis-related interventions. The inclusions of these costs have led to change results and conclusions in economic evaluations carried out in MS field.

WP5

Presentation at a Conference

22-Sep-20

Virtual

The results on patient preferences were presented at the Virtual EuroQol Plenary Meeting 2020 which was organized by the EuroQol Research Foundation. The paper titled “To what extent do patient preferences differ from general population preferences?” was presented and discussed at that conference. The EuroQol Plenary meetings take place every year and invite all members of the EuroQol Group Association, an international network of multidisciplinary researchers, as well as external researchers that focus their work on EQ-5D instruments to present and discuss their work.

WP5

Presentation at a Conference

17-Sep-20

Virtual

The results on the comparison of adult and adolescents’ preferences were presented at the Virtual EuroQol Plenary Meeting 2020 which was organized by the EuroQol Research Foundation. The paper titled “Comparison of adult and adolescent preferences towards EQ-5D-Y health states” was presented and discussed at that conference. The EuroQol Plenary meetings take place every year and invite all members of the EuroQol Group Association, an international network of multidisciplinary researchers, as well as external researchers that focus their work on EQ-5D instruments to present and discuss their work.

WP5

Presentation at a Conference

24-Sep-20

Virtual

The preliminary results on the Spanish EQ-5D-Y value set were presented at the Virtual EuroQol Plenary Meeting 2020 which was organized by the EuroQol Research Foundation. The paper titled “Modelling Strategies for generating country-specific EQ-5D-Y value sets” was presented and discussed at that conference. The EuroQol Plenary meetings take place every year and invite all members of the EuroQol Group Association, an international network of multidisciplinary researchers, as well as external researchers that focus their work on EQ-5D instruments to present and discuss their work.

WP5

Website of the Department of Health Economics and Health Care Management at Bielefeld University

Since 21 June 2021

Virtual

A short report and the video on the final Impact HTA Workshop was put on the website of the Department of Health Economics and Health Care Management at Bielefeld University to inform the interested public on current research activities. Link: https://www.uni-bielefeld.de/fakultaeten/gesundheitswissenschaften/ag/ag5/aktuelles/

WP5

Participation at a workshop

22–25 June 2021

Virtual

A poster on the results on the Spanish EQ-5D-Y value set was involved in a workshop on valuing Youth health, held by the EuroQol Research Foundation in June 2021. At this workshop, current work and evidence on that topic was presented and recommendations for the future were discussed. A group of interested members of the EuroQol Group Association and experts in this research field were invited to participate.

WP5

Participation at a workshop

22–25 June 2021

Virtual

A poster on the preliminary results on the German EQ-5D-Y value set was involved in a workshop on valuing Youth health, held by the EuroQol Research Foundation in June 2021. At this workshop, current work and evidence on that topic was presented and recommendations for the future were discussed. A group of interested members of the EuroQol Group Association and experts in this research field were invited to participate.

WP5

Website of the Institute for Economic Research, Ljubljana, Slovenia

Since 10 February 2021

Online

A short report on the final IMPACT HTA results was put on the website of the Institute for Economic Research of Slovenia to inform the interested public on the results of the project and research activities. Link: http://www.ier.si/files/IMPACT%20HTA%20brosura.pdf. The article published in PharmacoEconomics on Slovenian EQ-5D-Y value set was published on the website of the Institute for Economic Research of Slovenia to inform the interested public on the availability of Slovenian EQ-5D-Y values. Link: http://www.ier.si/menu-273.php

WP5

Website of DOBA Faculty

Since 23 February 2021

Online

The article published in PharmacoEconomics on Slovenian EQ-5D-Y value set was published on the website of DOBA Faculty of Slovenia to inform the interested public on the availability of Slovenian EQ-5D-Y values. https://www.doba.si/novice/izjemen-dosezek-visokosolske-uciteljice-doba-fakultete

WP5

Mailing

02-Jul-21

Emails

A final IMPACT HTA brochure with the results of the project was sent by email to all major stakeholders in Slovenia healthcare and long-term care (Health Insurance Institute of Slovenia, Ministry of Health, University Clinical Centres, National Institute for Public Health, Association of Institutional CARE OF Slovenia, Association of Community Care of Slovenia

WP6

Conference presentation

23-Nov-19

Marseille, France

European Public Health Conference. Can we rely on non-randomised studies as input for health economic decision-making? Findings from a meta-epidemiological review and evidence-based recommendations.

WP6

Conference presentation

28-Feb-20

Vienna, Austria

ATHEA conference. Agreement of treatment effects in randomised vs. non-randomised studies: preliminary findings from a meta-epidemiological study.

WP6

Guest lecture

23-Apr-20

Virtual

NICE Technical Forum: Agreement of treatment effects in randomised vs. non-randomised studies: findings from a large-scale meta-epidemiological study.

WP6

Workshop

26-Jun-20

Virtual

IMPACT HTA WP6 workshop on the use of non-randomised evidence for comparative effectiveness estimation.

WP7

Course

Sep-19

London, UK

LSE Market Access Academy: Value assessment, HTA and MCDA (module 4)

WP7

Trade fair: Conference presentation

15-Oct-19

Cairo, Egypt

DIA Middle East Regulatory Conference (MERC): HTA in the Middle East: Where can we invest and where can we build our capabilities?

WP7

Conference presentation

03-Nov-19

Copenhagen, Denmark

ISPOR 2019 – HTA Roundtable: IMPACT HTA project presentation

WP7

Conference presentation

20-Nov-19

Murcia, Spain

14th Scientific Re-union on Health Technology Assessment from a societal perspective: EU cooperation in HTA: Failing, flawed or fair?

WP7

Conference presentation

18-Feb-20

Athens, Greece

2nd HTA Conference: Reflections on HTA in Greece and ways forward

WP7

Trade fair: Conference presentation & seminar

25-Feb-20

Dubai, UAE

Dubai International Pharmaceuticals and Technologies Conference (DUPHAT) 2020: Multi-Criteria Decision Analysis for Health Technology Assessment: Which agenda to address methodological challenges?

WP7

Conference presentation

20-Aug-20

Beijing, China (virtual)

HTAi conference 2020: On value frameworks and value assessment

WP7

Seminar

07-Sep-20

Virtual

Politicas de medicamentos y regulación de precios II: A course on value assessment and risk mitigation: multi-criteria decision analysis and risk sharing

WP7

Conference presentation

16-Dec-20

Dubai, UAE (virtual)

Emirates Health Economics Society – Inauguration event: Towards a holistic approach to Health Technonlogy Assessment: From horizon Scanning to funding decisions

WP7

Seminar

20-21 January 2021

London, UK (virtual)

LSE Departmental seminar: Algorithms and heuristics of health technology assessments: A post hoc analysis of factors associated with funding decisions for new drugs across 8 OECD countries

WP7

Conference organization & Conference presentation

23-Mar-21

Athens, Greece (virtual)

3rd HTA Conference: The future of HTA relies on EU Member State cooperation

WP7

Conference presentation

15-Apr-21

virtual

EUnetHTA Forum 2021: Presentation of the IMPACT HTA project and its achievements

WP7

Seminar

02-Jun-21

Rome, Italy (virtual)

Catholic University of the Sacred Heart: Algorithms and heuristics of health technology assessments: A post hoc analysis of factors associated with funding decisions for new drugs across 8 OECD countries

WP7

Workshop

Jun-21

Manchester, UK (virtual)

HTAi conference 2021: Applying co-creation process for development and consensus-building in comprehensive genomic profiling and next generation sequencing value assessment framework in Europe

WP7

Course

23-Jun-21

Basel Switzerland (virtual)

ECPM Continuing Education Series – Integrated product development, healthcare marketplace and marketing: Health Technology Assessment

WP7

Course

Sep-19

London, UK

LSE Market Access Academy: Value assessment, HTA and MCDA (module 4)

WP7

Workshop presentation

05-Jul-19

London, UK

Combining Web-Delphi with Decision Conferencing within a Collaborative Value Modelling frame: Case Studies

WP7

Conference presentation

30-Jul-19

Karlsruhe, Germany

ORAHS2019 Conference: A multicriteria framework to assist HTA agencies on the evaluation of new drugs on a common basis.

WP7

Conference organization

September 1-8 2019

Lisbon, Portugal

Euro PhD summer school ‘Operational Research for Value-based Health Care’ 

WP7

Workshop participation

4-5 October 2019

London, UK

International Decision Conferencing Forum

WP7

Conference presentation

29-Jul-20

Virtual

ORAHS2020 Conference: Designing Delphi knowledge construction processes to enable OR behavioural research and extend stakeholders’ analyses in health settings.

WP7

Workshop presentation

21-Oct-20

Virtual

8th Conference of the Portuguese Association of Hospital Administrator “Innovate and lead under uncertainty”, “Operational Research in health care: which role for improving hospital management?”, Workshop in session: “E-LEARNING: Health service data simulation and predictive results”.

WP7

Seminar

29-Jun-21

Virtual

JointHealth: Digital Health Solutions Spring Welcome Seminars (Health Cluster Portugal and EIT Health): Operational Research and Decision Support Tools in Health Care: Which role for improving hospital management?

WP7

Conference presentation

06-Jul-21

Virtual

ORAHS2021 Conference: Designing and testing the IMPACT HTA socio-technical framework to assist HTA agencies in the multicriteria evaluation of new medicines on a common basis.

WP7

Conference presentation

12-Jul-21

Virtual

EURO2021 Conference: Designing and testing the IMPACT HTA socio-technical framework to assist HTA agencies in the multicriteria evaluation of new medicines on a common basis.

WP9

Conference

10-Oct-19

Milan, Italy

Italian Society of HTA (SIHTA)

WP9

Conference

28-Jan-20

Milan, Italy

Italia Longeva (National Association for Aging and Active Longevity)

WP10

Conference Presentation

Jul-19

Basel, switzerland

iHEA: Predicting Health Utilities from Patient-Reported Outcome Measures (PROMs) in Rare Diseases: a systematic review and quality appraisal of ‘mapping’ studies

WP10

Conference Presentation

Oct-19

Pisa, Italy

AIES: Predicting health utilities from PROMs in rare diseases: a systematic review of mapping studies

WP10

Conference Presentation

Oct-19

Basel, Swiizerland

DIA ATMPs workshop: RWE for decisions about highly innovative technologies

WP10

Conference Poster

Nov-19

Copenhagen, Denmark

ISPOR Europe 2019: Predicting health utilities from patient reported outcome measures in rare diseases: a systematic review of mapping studies

WP10

Conference Panel

Nov-19

Virtual

World Orphan Drug Conference Europe 2019: RWE and Early Dialogues for HTA of rare disease treatment

WP10

HTA/Policy Meeting

Mar-20

Virtual

NICE Methods Review: Presentation of results to NICE Executive team

WP10

Conference Panel

May-20

Virtual

ECRD 2020: Do we need special processes to appraisal rare disease treatments?

WP10

Workshop Panel Moderation

May-20

Virtual

DIA ATMPs workshop: Resolving HTA/Payer uncertainties with real-world evidence (RWE)

WP10

Conference Panel

Jun-20

Virtual

PSI 2020: RWE for HTA of highly innovative technologies

WP10

Press Release

Aug-20

Online

Orphanet newsletter to announce the publication of one peer review paper and our partnerships with them on Orphanet hosting WP10 IMPACT-HTA country vignettes of appraisal processes for rare disease treatments

WP10

Conference Panel

Sep-20

Virtual

HTAi 2020: Do we need special processes to appraise rare disease treatments?

WP10

Conference Keynote

Oct-20

Virtual

ODRD Conference 2020: Appraising orphan drugs – how should we determine value?

WP10

Conference Panel

Nov-20

Virtual

World Orphan Drug Conference Europe 2020: Special processes to appraise rare disease treatments – developing feasible, consistent approaches

WP10

Conference Panel

Nov-20

Virtual

ISPOR Europe 2020: HTA need special approaches for patient reported outcomes in rare diseases?

WP10

Conference Presentation

Nov-20

Virtual

ISPOR Europe 2020: Using PROMs in HTA for rare diseases

WP10

HTA/Policy Meeting

Dec-20

Virtual

Association of British Pharmaceutical Industries, Scotland: Presentation on OBMEA and draft tools

WP10

Workshop Series

Jan-20

Virtual

Webinar #1: Special processes to appraise rare disease treatments – developing feasible, consistent approaches

WP10

Workshop Series

Feb-21

Virtual

Webinar #2: Outcomes-Based Managed Entry Agreements for Rare Disease Treatments

WP10

Workshop Series

Mar-21

Virtual

Webinar #3: Better use of Patient Reported Outcome Measures and Health State Utility Values in appraisal of Rare Disease Treatments

WP10

Workshop Series

May-21

Virtual

Webinar #4: Appraisal Framework suitable for Rare Disease Treatments

WP10

Conference Presentation

Mar-21

Virtual

HTA conference - The role of HTA in the era of radical changes & disruptive innovation (Greece): Do we need special processes to appraisal rare disease treatments?

WP10

HTA/Policy Meeting

Mar-21

Virtual

RWE4Decisions discussion with DG Santé: Sharing of OBMEA findings

WP10

HTA/Policy Meeting

Apr-21

Virtual

Scottish Government: Presentation on OBMEA tools

WP10

HTA/Policy Meeting

May-21

Virtual

OECD Expert Group on Pharmaceuticals and Medical Devices: Presentation on OBMEA tools and links to OECD work

WP10

HTA/Policy Meeting

May-21

Virtual

CADTH scientific team: Discussion of OBMEA tools and granting of permission to use in new RWE processes

WP10

HTA/Policy Meeting

May-21

Virtual

SMC Leaders: Confidential feedback on ethnographic observations

WP10

Social Media

Continuous

Online

Many LinkedIn and twitter posts relating to WP10 presentations from the WP10 Principal Inverstigators’ accounts

WP10

Conference Panel

Jun-21

Virtual

HTAi 2021: Innovating HTA to support novel interventions for rare diseases

WP10

Conference Panel

Jun-21

Virtual

HTAi 2021: Using OBMEA to develop evidence for RDTs

WP10

Conference Workshop

Jun-21

Virtual

HTAi 2021: Patient group submission template for re-appraisal after OBMEA

WP10

Conference Presentation

Jun-21

Virtual

Canadian Organisation for Rare Diseases: Presentation of Appraisal Framework to inform Canadian development of rare disease policy

WP11

Conference Poster

Nov-19

Copenhagen. Denmark

ISPOR Europe 2019: Annual cost of patients undergoing a total knee replacement in France

WP11

Conference Poster

Nov-19

Copenhagen. Denmark

ISPOR Europe 2019: Budget impact analysis of triple therapy after failure of methotrexate for the treatment of rheumatoid arthritis in France

WP11

Workshop

03-Apr-21

Virtual

A technical workshop with stakeholders was organized. It gathered 16 French decision-makers, including members from the French social security, from the drug pricing committee (CEPS), the HAS Economics and Public Health Assessment Committee (CEESP) and researchers from economics and public health research institutes.

WP12

IMPACT HTA Website

2018-2026

Online

All WPs’ outputs are hosted on the IMPACT HTA website (freely accessible) for 5 years following the end of the project

WP12

Conference Presentation

Nov-19

Copenhagen, Denmark

ISPOR 2019 - HTA Roundtable 2019: Presenting IMPACT HTA’s objectives and WPs

WP12

Press Release

Feb-20

Online

EUnetHTA Bulletin: brief description of IMPACT HTA, its objectives, WPs and expected impacts

WP12

Workshop

Jun-21

Virtual

IMPACT HTA Final workshop

WP12

Report

Jun-21

Online

IMPACT HTA - Improved methods and actionable tools for enhancing HTA. Published on the project website and disseminated through social media

WP12

Press Release

Jun-21

Online

LSE Health newsletter to announce the conclusion of IMPACT HTA and the publication of the project report and workshop material.

WP12

Social Media

Continuous

Online

LinkedIn and twitter posts from LSE Health Policy and MTRG accounts to disseminate news about events (final workshop, meetings, etc) and reports and outputs

DICE trainings performed with the agencies and with academic teams involved in HTA

25-Feb-21

Association for Regenerative Medicine Foundation

DICE Model Demo

09-Mar-21

DMC (Danish Medicine Council)

DICE Training

05-May-21

CADTH

DICE Training

Q1 2021

National University of Singapore (NUS)

DICE Training

Jun-21

DICE Model Cost Effectiveness in Health Care

LSE HE Course

20-Apr-21

University of Warwick

Introduction to DICE

22-Jan-20

U MASS Medical & ICER

DICE Model Demo

20-Feb-20

iHEA Webinar

DICE for Modelling Obesity

01-Jul-20

HTAi Annual Meeting

Making HTA Easier: DICE

28-Sep-20

14th Vaccine Congress

SARS-COV-2 Vaccine DICE

20-Oct-20

Annual Meeting SMDM

DICE COVID-19-ICU LOS

03-Dec-20

ICPE

COVID-19 DICE model

Jul-20

US National Institute of Health (NIH)

WAVE Model Demo

27-Oct-20

LSE

DES for HTA

20-Apr-20

Dutch Authorities (ZINL)

DICE Training

21-Sep-20

NUS (National University of Singapore)

Introduction to DICE

13-Oct-20

SMDM

Designing a DICE

11-Jan-19

AOTMIT, Poland

DICE Training

16-Jan-19

York University

DICE Training

06-Mar-19

URC ECO

DICE Training

09-Apr-19

Hospinnomics, Paris

DICE Training

10-Apr-19

URC Eco, Paris

DICE Training

18-Apr-19

ICER, Boston

DICE Training

25-Apr-19

NICE, London

DICE Training

03-Nov-19

ISPOR EU, Copenhagen

DICE Course

26-Feb-19

NUS (National University of Singapore)

DICE Training

19-May-19

ISPOR Intl, New Orleans

DICE Course

16-Jun-19

HTAi Annual Meeting

DICE for HTA

12-Sep-19

ISPOR Latin America

Modelos en DICE

15-Jul-19

University of Sheffield / ScHARR

DICE Training

29-Oct-19

York University

DICE Training

25-Jul-18

NICE, London

DICE Training

17-Sep-18

Institute for Health Economics

DICE Training

31-Oct-18

ARM Foundation

DICE Training

09-Nov-18

NICE, London

DICE Training

21-Mar-18

Society of Clin Pharmacology & Therapeutics

DICE Demo

20-May-18

ISPOR Intl, Baltimore

DICE Course

10-Sep-18

ISPOR Asia, Tokyo

DICE Course

11-Nov-18

ISPOR EU, Barcelona

DICE Course